HomeCompareBLL vs MRK

BLL vs MRK: Dividend Comparison 2026

BLL yields 9.19% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLL wins by $300.3K in total portfolio value
10 years
BLL
BLL
● Live price
9.19%
Share price
$69.49
Annual div
$6.39
5Y div CAGR
32.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$358.0K
Annual income
$154,830.32
Full BLL calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — BLL vs MRK

📍 BLL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLLMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLL + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLL pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLL
Annual income on $10K today (after 15% tax)
$781.35/yr
After 10yr DRIP, annual income (after tax)
$131,605.77/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, BLL beats the other by $123,009.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLL + MRK for your $10,000?

BLL: 50%MRK: 50%
100% MRK50/50100% BLL
Portfolio after 10yr
$207.9K
Annual income
$82,472.05/yr
Blended yield
39.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BLL
No analyst data
Price Target
$63.50
-8.6% upside vs current
Range: $60.00 — $67.00
Altman Z
2.8
Piotroski
8/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLL buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLLMRK
Forward yield9.19%2.81%
Annual dividend / share$6.39$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR32.2%32.7%
Portfolio after 10y$358.0K$57.7K
Annual income after 10y$154,830.32$10,113.78
Total dividends collected$311.3K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$63.50$128.54

Year-by-year: BLL vs MRK ($10,000, DRIP)

YearBLL PortfolioBLL Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,915$1,215.22$11,213$373.04+$702.00BLL
2$14,538$1,788.98$12,667$512.06+$1.9KBLL
3$18,253$2,696.89$14,439$708.14+$3.8KBLL
4$23,714$4,183.40$16,640$988.16+$7.1KBLL
5$32,089$6,715.06$19,432$1,394.07+$12.7KBLL
6$45,562$11,226.64$23,057$1,992.90+$22.5KBLL
7$68,446$19,694.41$27,889$2,894.79+$40.6KBLL
8$109,791$36,554.00$34,518$4,286.29+$75.3KBLL
9$189,920$72,444.09$43,912$6,494.35+$146.0KBLL
10$358,045$154,830.32$57,714$10,113.78+$300.3KBLL

BLL vs MRK: Complete Analysis 2026

BLLStock

Ball Corporation supplies aluminum packaging products for the beverage, personal care, and household products industries in the United States, Brazil, and internationally. It operates through four segments: Beverage Packaging, North and Central America; Beverage Packaging, Europe, Middle East and Africa; Beverage Packaging, South America; and Aerospace. The company manufactures and sells aluminum beverage containers to fillers of carbonated soft drinks, beer, energy drinks, and other beverages. It also develops spacecraft, sensors and instruments, radio frequency systems, and other technologies for the civil, commercial, and national security aerospace markets, as well as offers defense hardware, antenna and video tactical solutions, civil and operational space hardware, and systems engineering services. In addition, the company designs, manufactures, and tests satellites, remote sensors, and ground station control hardware and software; and provides launch vehicle integration and satellite operational services. Further, it offers target identification, warning, and attitude control systems and components; cryogenic systems and associated sensor cooling devices; star trackers; and fast-steering mirrors to the government agencies or their prime contractors. Additionally, the company manufactures and sells extruded aluminum aerosol containers, recloseable aluminum bottles, aluminum cups, and aluminum slugs. Ball Corporation was founded in 1880 and is headquartered in Westminster, Colorado.

Full BLL Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BLL vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLL vs SCHDBLL vs JEPIBLL vs OBLL vs KOBLL vs MAINBLL vs JNJBLL vs ABBVBLL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.